Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹27,773.5
₹59,017 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,688.0
₹33,582 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹777.3
₹7,046 Cr
Pharmaceuticals & Drugs
₹437.3
₹6,883 Cr
Pharmaceuticals & Drugs
₹376.7
₹3,438 Cr
Pharmaceuticals & Drugs
₹275.6
₹3,085 Cr
Pharmaceuticals & Drugs
₹95.1
₹2,441 Cr
Pharmaceuticals & Drugs
₹689.1
₹393 Cr
Pharmaceuticals & Drugs
₹42.7
₹208 Cr
Pharmaceuticals & Drugs
₹62.4
₹177 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,688.0
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹437.3
₹4,108 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹376.7
₹2,477 Cr
Pharmaceuticals & Drugs
₹777.3
₹1,906 Cr
Pharmaceuticals & Drugs
₹275.6
₹707 Cr
Pharmaceuticals & Drugs
₹95.1
₹224 Cr
Pharmaceuticals & Drugs
₹42.7
₹111 Cr
Pharmaceuticals & Drugs
₹27,773.5
₹6,714 Cr
Pharmaceuticals & Drugs
₹689.1
₹316 Cr
Pharmaceuticals & Drugs
₹62.4
₹428 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,688.0
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹437.3
₹323 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹777.3
₹242 Cr
Pharmaceuticals & Drugs
₹376.7
₹199 Cr
Pharmaceuticals & Drugs
₹275.6
₹151 Cr
Pharmaceuticals & Drugs
₹95.1
₹144 Cr
Pharmaceuticals & Drugs
₹42.7
₹5 Cr
Pharmaceuticals & Drugs
₹27,773.5
₹1,509 Cr
Pharmaceuticals & Drugs
₹689.1
₹-15 Cr
Pharmaceuticals & Drugs
₹62.4
₹4 Cr

You may also like the below Video Courses